Corporate Banner
Satellite Banner
Technology Networks Header
Monday, July 28, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
UT Southwestern Researchers Uncover New Brain Pathways
New therapies for treating Type 2 diabetes and obesity.
Mass Spec-Based Metabolomics Workflows to Evaluate Plant Immunity
This article reviews metabolomics studies used to evaluate plant immunity with an emphasis on mass spectrometry in its many forms.
Assessing Anticancer Drugs Efficacy by Amino Acid Metabolomics
Researchers aimed to develop a method that determines the therapeutic efficacy of anticancer drugs based on the changes in amino acid metabolism at the cellular level.
Time Of Day Crucial to Accurately Test for Diseases
A new study published in PNAS has found that time of day and sleep deprivation have a significant effect on our metabolism.
When Drugs Do More Harm Than Good for Type 2 Diabetes Patients
Harm to quality of life outweighs benefits of treatment for older patients and those with negative feelings about side effects.
Inflammation in Fat Tissue Helps Prevent Metabolic Disease
The findings were first published online June 12 in Cell Metabolism.
Evaluating Acute Hydrogen Sulfide Poisoning in Rats through Serum Metabolomics
Through the use of GC/MS-based metabolomics, researchers have evaluated the effect of acute hydrogen sulfide poisoning on the metabolic profiles of rats.
Pathway Between Gut and Liver Regulates Bone Mass
Researchers have uncovered a previously unknown biological process involving vitamin B12 and taurine that regulates the production of new bone cells.
Study Explains How Green Tea Could Reduce Pancreatic Cancer Risk
The study published in the journal, Metabolomics, offers an explanation that researchers say could open a new area of cancer-fighting research.
Fatty Liver Disease Prevented in Mice
Blocking a path that delivers dietary fructose to the liver prevented mice from developing the condition, according to investigators.
Scroll Up
Scroll Down
Return
The Application of Metabolic Profiling Techniques in Biomarker Discovery in Drug R&D
Dr. Ina Schuppe Koistinen, AstraZeneca R&D speaking at Advances in Metabolic Profiling 2005
Date Posted: Thursday, February 02, 2006
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



AstraZeneca to Acquire Bristol-Myers Squibb Share of Global Diabetes Alliance Assets
Global agreement strengthens AstraZeneca’s commitment to diabetes.
Monday, December 23, 2013
AstraZeneca to Acquire Omthera Pharmaceuticals
Acquisition includes the take-over of NDA-ready novel dyslipidemia treatment to complement cardiovascular portfolio.
Wednesday, May 29, 2013
Palatin Technologies Announces Extension of Research Collaboration and License Agreement with AstraZeneca
Both companies enter into clinical trial sponsored research agreement to conduct a study of the effects of melanocortin receptor specific compounds.
Wednesday, December 10, 2008
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv